FI870457A0 - Farmaceutiska preparatformer foer stabilisering av interferon- . - Google Patents

Farmaceutiska preparatformer foer stabilisering av interferon- .

Info

Publication number: FI870457A0
Authority: FI; Finland
Prior art keywords: active ingredient; stabilization; interference; pharmaceutical form; ifn alpha
Prior art date: 1986-02-05

Application number

FI870457A

Other languages

English (en)

Other versions

FI870457A (fi

FI86144B (fi

FI86144C (fi

Inventor

Helmut Franz

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-05

Filing date

1987-02-03

Publication date

1987-02-03

1987-02-03 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1987-02-03 Publication of FI870457A0 publication Critical patent/FI870457A0/fi

1987-08-06 Publication of FI870457A publication Critical patent/FI870457A/fi

1992-04-15 Publication of FI86144B publication Critical patent/FI86144B/fi

1992-07-27 Application granted granted Critical

1992-07-27 Publication of FI86144C publication Critical patent/FI86144C/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FI870457A 1986-02-05 1987-02-03 Foerfarande foer framstaellning av farmaceutiska preparatformer foer topisk anvaendning foer stabilisering av -interferon. FI86144C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19863603444 DE3603444A1 (de)	1986-02-05	1986-02-05	Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3603444		1986-02-05

Publications (4)

Publication Number	Publication Date
FI870457A0 true FI870457A0 (fi)	1987-02-03
FI870457A FI870457A (fi)	1987-08-06
FI86144B FI86144B (fi)	1992-04-15
FI86144C FI86144C (fi)	1992-07-27

Family

ID=6293372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI870457A FI86144C (fi)	1986-02-05	1987-02-03	Foerfarande foer framstaellning av farmaceutiska preparatformer foer topisk anvaendning foer stabilisering av -interferon.

Country Status (20)

Country	Link
EP (1)	EP0231816B1 (fi)
JP (1)	JPS62209024A (fi)
KR (1)	KR870007698A (fi)
AT (1)	ATE63823T1 (fi)
AU (1)	AU601712B2 (fi)
CA (1)	CA1295242C (fi)
DD (1)	DD284602A5 (fi)
DE (2)	DE3603444A1 (fi)
DK (1)	DK164202C (fi)
ES (1)	ES2028796T3 (fi)
FI (1)	FI86144C (fi)
GR (1)	GR3002270T3 (fi)
HU (1)	HU196560B (fi)
IE (1)	IE59697B1 (fi)
IL (1)	IL81472A0 (fi)
NO (1)	NO169638C (fi)
NZ (1)	NZ219169A (fi)
PH (1)	PH24377A (fi)
PT (1)	PT84243B (fi)
ZA (1)	ZA87793B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5275804A (en) *	1986-02-25	1994-01-04	E. B. Michaels Research Associates, Inc.	Process and composition for oral hygiene
DE3731255A1 (de) *	1987-09-17	1989-04-06	Boehringer Ingelheim Int	Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) *	1987-09-17	1993-11-30	Boehringer Ingelheim International Gmbh	Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3803312A1 (de) *	1988-02-04	1989-08-10	Gerd Prof Dr Med Gross	Verwendung eines interferonenthaltenden gels
NO179479C (no) *	1988-03-11	1996-10-16	Teikoku Seiyaku Kk	Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
EP0374257B1 (en) *	1988-05-06	1994-08-31	Toray Industries, Inc.	STABLE INTERFERON $g(b) COMPOSITION
US5244652A (en) *	1991-03-22	1993-09-14	E. B. Michaels Research Associates, Inc.	Viscous surface active composition
US5389676A (en) *	1991-03-22	1995-02-14	E. B. Michaels Research Associates, Inc.	Viscous surfactant emulsion compositions
CA2120950A1 (en) *	1991-10-11	1993-04-15	Mark C. Gillies	Treating ophthalmic fibrosis using interferon-alpha
US5863530A (en) *	1991-10-11	1999-01-26	Spruson & Ferguson	Treating ophthalmic fibrosis using interferon-α
US6630168B1 (en)	1997-02-20	2003-10-07	Biomedicines, Inc.	Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) *	1998-06-10	2001-02-15	Suomen Punainen Risti Veripalv	Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en)	1999-04-08	2005-08-02	Schering Corporation	Melanoma therapy
JP4536194B2 (ja) *	2000-02-17	2010-09-01	大日本住友製薬株式会社	安定な注射用製剤
PL202918B1 (pl) *	2000-03-07	2009-08-31	Rush Presbyterian St Luke	Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
US6328987B1 (en) *	2000-11-03	2001-12-11	Jan Marini Skin Research, Inc.	Cosmetic skin care compositions containing alpha interferon
WO2003037375A1 (fr) *	2001-11-02	2003-05-08	Sekisui Chemical Co., Ltd.	Substance d'induction de cytokine et instrument d'induction de cytokine
US8137677B2 (en) *	2005-10-06	2012-03-20	Allergan, Inc.	Non-protein stabilized clostridial toxin pharmaceutical compositions
CA2761963C (en) *	2009-05-29	2018-03-20	Filligent Limited	Composition for use in decreasing the transmission of human pathogens
SG11201405359YA (en)	2012-03-01	2014-09-26	Firststring Res Inc	Topical gels containing alpha connexin c-terminal (act) peptides
JP6081156B2 (ja) *	2012-11-15	2017-02-15	アルケア株式会社	ハイドロゲル
DE102012222365A1 (de)	2012-12-05	2014-06-05	Aesculap Ag	Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
EP3007720A4 (en) *	2013-06-09	2016-12-07	Efranat Ltd	COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF
KR102679493B1 (ko)	2017-01-31	2024-07-01	킴벌리-클라크 월드와이드, 인크.	벤조산 에스테르를 포함하는 항균 조성물 및 이를 이용한 세균 생장 억제 방법
MX2023004631A (es)	2020-10-22	2023-07-20	Xequel Bio Inc	Formulaciones peptidicas y usos oftalmicos de las mismas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1234383A (en) *	1982-03-17	1983-09-22	Inter-Yeda Ltd.	Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) *	1983-08-24	1985-04-09	エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト	製薬学的組成物
JPS6069037A (ja) *	1983-09-26	1985-04-19	Sunstar Inc	エリテマト−デス治療用外用剤
EP0139286B1 (en) *	1983-10-14	1991-08-21	Sumitomo Pharmaceuticals Company, Limited	Prolonged sustained-release preparations
US4680175A (en) *	1984-02-07	1987-07-14	Interferon Sciences, Inc.	Interferon administration vehicles
CA1248450A (en) *	1984-04-05	1989-01-10	Kazuo Kigasawa	Soft patch
JPS60228422A (ja) *	1984-04-26	1985-11-13	Suntory Ltd	安定化された生理活性物質製剤
JPS60260523A (ja) *	1984-06-07	1985-12-23	Asahi Chem Ind Co Ltd	インタ−フエロンの凍結乾燥医薬組成物

1986
- 1986-02-05 DE DE19863603444 patent/DE3603444A1/de not_active Withdrawn
1987
- 1987-01-21 DE DE8787100792T patent/DE3770280D1/de not_active Expired - Lifetime
- 1987-01-21 AT AT87100792T patent/ATE63823T1/de not_active IP Right Cessation
- 1987-01-21 EP EP87100792A patent/EP0231816B1/de not_active Expired - Lifetime
- 1987-01-21 ES ES198787100792T patent/ES2028796T3/es not_active Expired - Lifetime
- 1987-02-03 FI FI870457A patent/FI86144C/fi not_active IP Right Cessation
- 1987-02-03 CA CA000528832A patent/CA1295242C/en not_active Expired - Lifetime
- 1987-02-03 DD DD87299676A patent/DD284602A5/de not_active IP Right Cessation
- 1987-02-04 IE IE29587A patent/IE59697B1/en not_active IP Right Cessation
- 1987-02-04 HU HU87385A patent/HU196560B/hu not_active IP Right Cessation
- 1987-02-04 IL IL81472A patent/IL81472A0/xx not_active IP Right Cessation
- 1987-02-04 ZA ZA87793A patent/ZA87793B/xx unknown
- 1987-02-04 AU AU68292/87A patent/AU601712B2/en not_active Ceased
- 1987-02-04 DK DK058387A patent/DK164202C/da not_active IP Right Cessation
- 1987-02-04 PT PT84243A patent/PT84243B/pt not_active IP Right Cessation
- 1987-02-04 NO NO870441A patent/NO169638C/no unknown
- 1987-02-04 JP JP62024423A patent/JPS62209024A/ja active Pending
- 1987-02-04 NZ NZ219169A patent/NZ219169A/en unknown
- 1987-02-05 KR KR870000912A patent/KR870007698A/ko not_active Application Discontinuation
- 1987-02-05 PH PH34815A patent/PH24377A/en unknown
1991
- 1991-07-08 GR GR91400966T patent/GR3002270T3/el unknown

Also Published As

Publication number	Publication date
CA1295242C (en)	1992-02-04
PT84243A (de)	1987-03-01
ES2028796T3 (es)	1992-07-16
HUT43494A (en)	1987-11-30
DK164202C (da)	1992-10-19
FI870457A (fi)	1987-08-06
ATE63823T1 (de)	1991-06-15
KR870007698A (ko)	1987-09-21
AU601712B2 (en)	1990-09-20
JPS62209024A (ja)	1987-09-14
DD284602A5 (de)	1990-11-21
EP0231816B1 (de)	1991-05-29
NO169638C (no)	1992-07-22
DE3603444A1 (de)	1987-08-06
PH24377A (en)	1990-06-13
GR3002270T3 (en)	1992-12-30
DK58387D0 (da)	1987-02-04
NO870441L (no)	1987-08-06
DK164202B (da)	1992-05-25
IE59697B1 (en)	1994-03-23
DK58387A (da)	1987-08-06
NO870441D0 (no)	1987-02-04
EP0231816A3 (en)	1987-09-23
PT84243B (pt)	1989-09-14
IE870295L (en)	1987-08-05
EP0231816A2 (de)	1987-08-12
AU6829287A (en)	1987-08-06
NO169638B (no)	1992-04-13
FI86144B (fi)	1992-04-15
DE3770280D1 (de)	1991-07-04
NZ219169A (en)	1990-04-26
HU196560B (en)	1988-12-28
ZA87793B (en)	1988-10-26
IL81472A0 (en)	1987-09-16
FI86144C (fi)	1992-07-27

Publication	Publication Date	Title
FI870457A0 (fi)	1987-02-03	Farmaceutiska preparatformer foer stabilisering av interferon- .
DE3581819D1 (de)	1991-04-04	Pyridazinamine wirksam gegen viren.
FI871750A0 (fi)	1987-04-22	Nasal administration av laekemedel.
ATE188119T1 (de)	2000-01-15	Heilmittel für wunden und hämorrhoiden
IE781032L (en)	1978-11-25	Pharmaceutical compositions
NO165071C (no)	1990-12-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
KR890005088A (ko)	1989-05-11	4- 아미노피리딘 유도체 및 그의 산 부가염
AU1518492A (en)	1992-06-25	Pharmaceutical compositions for transcutaneous administration
GB2021409A (en)	1979-12-05	Pharmaceutical composition
IT8620208A0 (it)	1986-04-24	Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
FR2691149B1 (fr)	1994-07-08	Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
AU581856B2 (en)	1989-03-09	1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
FR2694005B1 (fr)	1994-08-26	Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FI894813A (fi)	1990-04-12	Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
EP0355899A3 (en)	1991-03-20	Nucleotide derivatives
DK0578535T3 (da)	1996-12-09	Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne
IT8125874A0 (it)	1981-12-29	Composizioni terapeutiche adattivita' coleretica contenenti come principio attivo derivati dall'acido colanico.
NO863005D0 (no)	1986-07-25	Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
FR2691967B1 (fr)	1995-06-09	Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2567755B1 (fr)	1988-08-12	Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
IT8819541A0 (it)	1988-02-25	Composizione farmaceutica per somministrazione nasale.

Legal Events

Date	Code	Title	Description
1996-09-11	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: DR. KARL THOMAE GESELLSCHAFT MIT